348
Participants
Start Date
October 1, 2019
Primary Completion Date
July 15, 2020
Study Completion Date
May 5, 2021
Ceftazidime-Avibactam
Patients with complicated urinary tract infections, nosocomial pneumonia (including pneumonia associated with ventilation), complicated intra-abdominal infections or bacteremia (if the focus of infection is any of the above, the patient should be included in both groups) due to CRE, treated \> 2 days with ceftazidime-avibactam.
Best Available Therapy
Patients with complicated urinary tract infections, nosocomial pneumonia (including pneumonia associated with ventilation), complicated intra-abdominal infections or bacteremia (if the focus of infection is any of the above, the patient should be included in both groups) due to CRE, treated \> 2 days with the best available treatment other than ceftazidime-avibactam.
Hospital San Pedro de Alcántara, Cáceres
Hospital Universitario Reina Sofía, Córdoba
Complejo Hospitalario Universitario A Coruña, A Coruña
Hospital Universitario de La Princesa, Madrid
Hospital General Universitario Gregorio Marañón, Madrid
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Regional Universitario de Málaga, Málaga
"Hospital Universitario de Gran Canaria Dr. Negrín", Las Palmas de Gran Canaria
Hospital Álvaro Cunqueiro, Vigo
Hospital Universitario Marqués de Valdecilla, Santander
Hospital Clínico Universitario de Valencia, Valencia
Hospital General Universitario de Valencia, Valencia
Hospital Universitario y Politécnico La Fe, Valencia
Hospital Universitario de Bellvitge, L'Hospitalet de Llobregat
Hospital Universitario Vall d'Hebrón, Barcelona
Hospital Clínico de Barcelona, Barcelona
Maimónides Biomedical Research Institute of Córdoba
OTHER